Ally Bridge Group’s Atea Pharmaceuticals AVIR Stock Holding History

Ally Bridge Group’s Portfolio AVIR Stock Details AVIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell
2022 Q4	$4.63M	Buy
2022 Q3	$2.05M	Buy
2021 Q3	–	Sell
2021 Q2	$8.02M	Sell
2021 Q1	$55.8M	Sell
2020 Q4	$42.5M	Buy